Cardiogenic shock remains one of the most complex and life-threatening conditions in cardiovascular medicine, associated with persistently high morbidity and mortality.
Recognising the urgent need for structured, high-quality education, ACVC and EAPCI have joined forces to create this new School.
This collaboration introduces an innovative, two-tiered educational programme.
To ensure tailored and impactful learning, the programme is split into two complementary courses per year, each meeting distinct levels of expertise and educational needs:
- Level 1 (Paris, France - 2025) is designed for physicians new to mechanical circulatory support (MCS) or those introducing these technologies in their centres. This course provides a strong foundation in the principles of cardiogenic shock management and MCS initiation.
- Level 2 (Barcelona, Spain - 2026) is tailored for experienced clinicians who already manage cardiogenic shock patients and seek advanced insights into complex decision-making, clinical case simulation, hands-on escalation strategies, and MCS techniques.
Level 1
When: 8–9 September 2025
Where: Hotel Pullman Montparnasse, Paris
Target audience
Physicians new to mechanical circulatory support (MCS) and those introducing these technologies in their centres.
Learning objectives
A curriculum built around expert-led lectures, case-based discussions, hands-on simulations, and interactive workshops, to learn how to:
- Gain fundamental theoretical knowledge about cardiogenic shock, including its pathophysiology and classification.
- Engage in clinical case scenario discussions to enhance decision-making skills.
- Participate in hands-on sessions with simulators for mechanical circulatory support (MCS) placement and management.
- Develop competency in stratification and phenotypisation of cardiogenic shock.
- Master ICU management strategies, including weaning from MCS and escalation and handling complications.
- Understand advanced haemodynamic monitoring techniques and pharmacologic management.
- Gain expertise in MCS implantation techniques and their indications in various clinical settings.
Registration fees (including VAT)
- Non ACVC/EAPCI Member: €670
- ACVC/EAPCI Member: €570
- ACVC/EAPCI Young Member: €470
Registrations are closed
Hotel
You benefit from a preferential rate at Paris Pullman Montparnasse if you register to the course.
Level 2 is now open!
When: 14-15 January 2026
Where: Vall d'Hebron Hospital, Barcelona, Spain
Target audience
All physicians with experience in cardiogenic shock management seeking advanced insights into complex decision-making, escalation strategies, and technical expertise in MCS.
Workshops
- Shock Classification: Phenotype, Profiles and Severity
- Pharmacotherapy in Cardiogenic Shock
- Invasive Haemodynamics and Non-Invasive Perfusion and Congestion
- ECMO Unloading
- Microaxial Blood Pump Catheter
- Choice of the Appropriate MCS
- Airway Management and Mechanical Ventilation in Cardiogenic Shock
- Shock Team in Action: Interdisciplinary Care
Format
- Workshops are specifically designed for small groups to optimise learning outcomes
- Each group rotates among the workshops during two full days
Learning Objectives
- Differentiate and classify cardiogenic shock phenotypes, integrating clinical and hemodynamic profiles into tailored management strategies.
- Critically evaluate the role of vasoactive drugs, mechanical ventilation, and invasive monitoring in optimising shock stabilisation.
- Compare and contrast advanced MCS modalities (ECMO, microaxial pumps), including their indications, limitations, and timing of deployment.
- Formulate and defend evidence-based decisions in complex or ambiguous shock scenarios, with emphasis on escalation and de-escalation strategies.
- Demonstrate leadership in operationalising a high-performing shock team through interdisciplinary collaboration and crisis management.
Registration are now open!
Registration fees (including VAT)
- Non ACVC/EAPCI Member: €670
- ACVC/EAPCI Member: €570
- ACVC/EAPCI Young Member: €470
For any questions you can contact: escacute@escardio.org
Our mission: To reduce the burden of cardiovascular disease.